BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 32775436)

  • 1. A CT-Based Radiomics Approach for the Differential Diagnosis of Sarcomatoid and Clear Cell Renal Cell Carcinoma.
    Meng X; Shu J; Xia Y; Yang R
    Biomed Res Int; 2020; 2020():7103647. PubMed ID: 32775436
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clear cell renal cell carcinoma: CT-based radiomics features for the prediction of Fuhrman grade.
    Shu J; Tang Y; Cui J; Yang R; Meng X; Cai Z; Zhang J; Xu W; Wen D; Yin H
    Eur J Radiol; 2018 Dec; 109():8-12. PubMed ID: 30527316
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiomics analysis based on single phase and different phase combinations of radiomics features from tri-phasic CT to distinguish renal oncocytoma from chromophobe renal cell carcinoma.
    Yang S; Jian Y; Yang F; Liu R; Zhang W; Wang J; Tan X; Wu J; Chen Y; Zhou X
    Abdom Radiol (NY); 2024 Jan; 49(1):182-191. PubMed ID: 37907684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Can whole-tumor radiomics-based CT analysis better differentiate fat-poor angiomyolipoma from clear cell renal cell caricinoma: compared with conventional CT analysis?
    Ma Y; Cao F; Xu X; Ma W
    Abdom Radiol (NY); 2020 Aug; 45(8):2500-2507. PubMed ID: 31980867
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differentiation of renal cell carcinoma subtypes through MRI-based radiomics analysis.
    Wang W; Cao K; Jin S; Zhu X; Ding J; Peng W
    Eur Radiol; 2020 Oct; 30(10):5738-5747. PubMed ID: 32367419
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clear cell renal cell carcinoma: Machine learning-based computed tomography radiomics analysis for the prediction of WHO/ISUP grade.
    Shu J; Wen D; Xi Y; Xia Y; Cai Z; Xu W; Meng X; Liu B; Yin H
    Eur J Radiol; 2019 Dec; 121():108738. PubMed ID: 31756634
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CT-based multi-phase Radiomic models for differentiating clear cell renal cell carcinoma.
    Chen M; Yin F; Yu Y; Zhang H; Wen G
    Cancer Imaging; 2021 Jun; 21(1):42. PubMed ID: 34162442
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A CT-based radiomics nomogram for differentiation of renal angiomyolipoma without visible fat from homogeneous clear cell renal cell carcinoma.
    Nie P; Yang G; Wang Z; Yan L; Miao W; Hao D; Wu J; Zhao Y; Gong A; Cui J; Jia Y; Niu H
    Eur Radiol; 2020 Feb; 30(2):1274-1284. PubMed ID: 31506816
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differentiation of Clear Cell and Non-clear-cell Renal Cell Carcinoma through CT-based Radiomics Models and Nomogram.
    Cheng D; Abudikeranmu Y; Tuerdi B
    Curr Med Imaging; 2023; 19(9):1005-1017. PubMed ID: 36411581
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CT-based radiomic model predicts high grade of clear cell renal cell carcinoma.
    Ding J; Xing Z; Jiang Z; Chen J; Pan L; Qiu J; Xing W
    Eur J Radiol; 2018 Jun; 103():51-56. PubMed ID: 29803385
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A CT-based radiomics model for predicting renal capsule invasion in renal cell carcinoma.
    Yang L; Gao L; Arefan D; Tan Y; Dan H; Zhang J
    BMC Med Imaging; 2022 Jan; 22(1):15. PubMed ID: 35094674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differentiation of renal angiomyolipoma without visible fat from small clear cell renal cell carcinoma by using specific region of interest on contrast-enhanced CT: a new combination of quantitative tools.
    Wang X; Song G; Jiang H
    Cancer Imaging; 2021 Jul; 21(1):47. PubMed ID: 34225784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deep learning and radiomics: the utility of Google TensorFlow™ Inception in classifying clear cell renal cell carcinoma and oncocytoma on multiphasic CT.
    Coy H; Hsieh K; Wu W; Nagarajan MB; Young JR; Douek ML; Brown MS; Scalzo F; Raman SS
    Abdom Radiol (NY); 2019 Jun; 44(6):2009-2020. PubMed ID: 30778739
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A triple-classification for differentiating renal oncocytoma from renal cell carcinoma subtypes and CK7 expression evaluation: a radiomics analysis.
    Yu Z; Ding J; Pang H; Fang H; He F; Xu C; Li X; Ren K
    BMC Urol; 2022 Sep; 22(1):147. PubMed ID: 36096829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fuhrman nuclear grade prediction of clear cell renal cell carcinoma: influence of volume of interest delineation strategies on machine learning-based dynamic enhanced CT radiomics analysis.
    Luo S; Wei R; Lu S; Lai S; Wu J; Wu Z; Pang X; Wei X; Jiang X; Zhen X; Yang R
    Eur Radiol; 2022 Apr; 32(4):2340-2350. PubMed ID: 34636962
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Noninvasive Fuhrman grading of clear cell renal cell carcinoma using computed tomography radiomic features and machine learning.
    Nazari M; Shiri I; Hajianfar G; Oveisi N; Abdollahi H; Deevband MR; Oveisi M; Zaidi H
    Radiol Med; 2020 Aug; 125(8):754-762. PubMed ID: 32193870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CT-Based Radiomics Signature for Preoperative Prediction of Coagulative Necrosis in Clear Cell Renal Cell Carcinoma.
    Xu K; Liu L; Li W; Sun X; Shen T; Pan F; Jiang Y; Guo Y; Ding L; Zhang M
    Korean J Radiol; 2020 Jun; 21(6):670-683. PubMed ID: 32410406
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predicting the ISUP grade of clear cell renal cell carcinoma with multiparametric MR and multiphase CT radiomics.
    Cui E; Li Z; Ma C; Li Q; Lei Y; Lan Y; Yu J; Zhou Z; Li R; Long W; Lin F
    Eur Radiol; 2020 May; 30(5):2912-2921. PubMed ID: 32002635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiphase CT radiomics nomogram for preoperatively predicting the WHO/ISUP nuclear grade of small (< 4 cm) clear cell renal cell carcinoma.
    Gao Y; Wang X; Zhao X; Zhu C; Li C; Li J; Wu X
    BMC Cancer; 2023 Oct; 23(1):953. PubMed ID: 37814228
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Computed tomography-based radiomics prediction of CTLA4 expression and prognosis in clear cell renal cell carcinoma.
    He H; Jin Z; Dai J; Wang H; Sun J; Xu D
    Cancer Med; 2023 Mar; 12(6):7627-7638. PubMed ID: 36397666
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.